Regeneron COVID-19 Antibody Poised To Add Prevention Claim, Sub-Q Formula

 
• By Jessica Merrill

The company is requesting FDA expand the antibody cocktail to include a COVID prevention claim with a lower 1,200mg dose and a subcutaneously administered formula.

Vector illustration of monoclonal antibody for coronavirus treatment
Regeneron aims to broaden the reach of its COVID-19 antibody • Source: Alamy (srikijt / Alamy Stock Vector/Alamy Stock Vector)

More from COVID-19

More from Scrip